Cetuximab plus capecitabine as first-line treatment for elderly patients (pts) with advanced colorectal cancer (mCRC). Final analysis of activity and survival according to KRAS status - the TTD-06-01 Spanish Cooperative Group trial
- Rivera, F.
- Gravalos, C.
- Massuti, B.
- Puente, J.
- Marcuello, E.
- Valladares, M.
- Gutierrez, V.
- Layos, L.
- Diaz-Rubio, E.
- Aranda, E.
ISSN: 1359-6349
Year of publication: 2009
Volume: 7
Issue: 2
Pages: 216-216
Congress: 15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology
Type: Conference paper